HCR(SH:688500)2024-10-29 10:34Financial Performance - The company's operating revenue for Q3 2024 was ¥94,849,830.37, a decrease of 15.01% compared to the same period last year[2]. - The net profit attributable to shareholders of the listed company was -¥25,180, indicating a significant loss[3]. - The net profit for Q3 2024 was -64,417,883.10 RMB, compared to -23,270,638.81 RMB in Q3 2023, indicating a significant increase in losses[16]. - The total operating profit for Q3 2024 was -76,757,306.30 RMB, compared to -30,020,590.21 RMB in the same period last year, reflecting a worsening operational performance[16]. - The company reported a total comprehensive income of -64,426,147.91 RMB for Q3 2024, compared to -22,530,631.20 RMB in Q3 2023, indicating increased overall losses[17]. - The basic and diluted earnings per share for Q3 2024 were both -0.834 RMB, compared to -0.363 RMB in Q3 2023, reflecting a decline in shareholder value[18]. Cash Flow and Liquidity - The net cash flow from operating activities was -¥73,454,751.05, indicating a negative cash flow situation[3]. - Cash flow from operating activities for Q3 2024 was -73,454,751.05 RMB, compared to -36,895,283.31 RMB in Q3 2023, showing a decline in cash generation[19]. - Cash and cash equivalents at the end of Q3 2024 were 223,663,336.16 RMB, compared to 206,664,134.44 RMB at the end of Q3 2023, showing a slight increase in liquidity[20]. - The company generated 332,923,861.09 RMB in cash from sales and services in the first nine months of 2024, down from 395,419,434.44 RMB in the same period of 2023[18]. - Investment activities generated a net cash flow of 80,603,207.32 RMB in Q3 2024, compared to 91,371,689.45 RMB in Q3 2023, indicating a decrease in investment returns[19]. Research and Development - The R&D investment totaled ¥7,462,639.10, down 26.93% year-on-year, representing 7.87% of operating revenue[3]. - The total R&D investment from the beginning of the year to the end of the reporting period was ¥27,959,051.16, down 11.24% year-on-year[3]. - Research and development expenses for the first three quarters of 2024 amounted to CNY 27,959,051.16, a decrease of 11.4% from CNY 31,499,566.21 in the previous year[15]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,052,323,730.09, reflecting a decrease of 12.40% compared to the previous year[3]. - The company's total assets decreased to CNY 1,052,323,730.09 from CNY 1,201,342,417.54, representing a decline of 12.4%[14]. - Total liabilities decreased to CNY 322,130,181.59 from CNY 401,440,063.23, indicating a reduction of 19.7%[13]. - The company's total equity decreased to CNY 730,193,548.50 from CNY 799,902,354.31, reflecting a decline of 8.7%[14]. - The company's goodwill decreased significantly from CNY 17,403,699.41 to CNY 4,066,797.52, a reduction of 76.7%[12]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 3,434[9]. - The largest shareholder, Xinjiang Liangzhi Zhengde Enterprise Management Consulting Co., Ltd., holds 22.62% of the shares, totaling 16,803,750 shares[9]. - The company has a repurchase account holding 2,220,951 shares, accounting for 2.99% of the total share capital[11]. - There were no significant changes in the shareholding structure of the top ten shareholders during the reporting period[11]. Market Conditions - The company experienced intensified competition and cautious budget spending from some clients, impacting revenue[7]. - The total revenue from operating activities decreased by approximately 20.2% year-over-year in the first nine months of 2024[18]. - The company reported a total of -¥8,331,318.58 in non-recurring gains and losses for the current period[6]. - The company reported a significant increase in credit impairment losses, amounting to -3,372,278.76 RMB in Q3 2024, compared to 11,772,004.95 RMB in Q3 2023[16].